FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin.

PubWeight™: 5.75‹?› | Rank: Top 1%

🔗 View Article (PMID 1377361)

Published in Nature on June 25, 1992

Authors

S J O'Keefe1, J Tamura, R L Kincaid, M J Tocci, E A O'Neill

Author Affiliations

1: Department of Molecular Immunology, Merck Research Laboratories, Rahway, New Jersey 07065.

Articles citing this

(truncated to the top 100)

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01

Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J (1997) 3.67

Calcineurin-dependent growth control in Saccharomyces cerevisiae mutants lacking PMC1, a homolog of plasma membrane Ca2+ ATPases. J Cell Biol (1994) 3.59

Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev (1997) 3.40

Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. Mol Cell Biol (1995) 3.27

Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. EMBO J (1993) 2.92

Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J (1999) 2.62

The cyclophilins. Genome Biol (2005) 2.58

The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J (1994) 2.57

The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J Virol (1996) 2.43

Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci U S A (1994) 2.42

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40

Immunosuppressants implicate protein phosphatase regulation of K+ channels in guard cells. Proc Natl Acad Sci U S A (1993) 2.39

Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24

Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev (1999) 2.20

Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci U S A (1996) 2.19

AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J (1994) 2.08

Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J (1994) 2.06

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J (1994) 2.03

Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol (1996) 2.03

Calcineurin activity is required for the initiation of skeletal muscle differentiation. J Cell Biol (2000) 1.99

Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H(+)-ATPase. Mol Cell Biol (1995) 1.98

FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J (1995) 1.94

Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med (1993) 1.93

A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol (1995) 1.88

Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol (1993) 1.85

Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res (1993) 1.80

The PMR2 gene cluster encodes functionally distinct isoforms of a putative Na+ pump in the yeast plasma membrane. EMBO J (1995) 1.79

Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J (1998) 1.76

Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. Proc Natl Acad Sci U S A (1994) 1.72

Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci U S A (2002) 1.71

Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol (2003) 1.69

Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol Cell Biol (1995) 1.66

Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol Cell Biol (1995) 1.65

Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A (1995) 1.64

An essential role of the yeast pheromone-induced Ca2+ signal is to activate calcineurin. Mol Biol Cell (1997) 1.63

Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci U S A (2001) 1.63

Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol (1996) 1.61

Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. Genes Dev (2002) 1.59

Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci U S A (2003) 1.58

A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J (1994) 1.56

Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J Cell Biol (1995) 1.55

The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT. Mol Cell Biol (1993) 1.52

Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol (2000) 1.52

A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc Natl Acad Sci U S A (1995) 1.49

Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J (1995) 1.47

Immunophilins and parvulins. Superfamily of peptidyl prolyl isomerases in Arabidopsis. Plant Physiol (2004) 1.47

Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc Natl Acad Sci U S A (1996) 1.47

FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol (1995) 1.45

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med (1995) 1.45

Lovastatin attenuates effects of cyclosporine A on tight junctions and apoptosis in cultured cortical collecting duct principal cells. Am J Physiol Renal Physiol (2013) 1.44

T cell responses in calcineurin A alpha-deficient mice. J Exp Med (1996) 1.44

Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med (2016) 1.42

Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother (2000) 1.42

Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40

p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J Exp Med (1993) 1.40

Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients. Eur J Clin Pharmacol (2004) 1.39

Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus. Eukaryot Cell (2008) 1.37

The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. Proc Natl Acad Sci U S A (1993) 1.35

RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34

Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes. Mol Cell Biol (2007) 1.30

The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.30

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med (1992) 1.27

PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J (2001) 1.25

Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth. J Cell Biol (2000) 1.24

The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother (1997) 1.24

vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. Genetics (1995) 1.24

Light-regulated, tissue-specific immunophilins in a higher plant. Proc Natl Acad Sci U S A (1994) 1.24

Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells. J Exp Med (1994) 1.22

Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells. Mol Cell Biol (1997) 1.22

pCyP B: a chloroplast-localized, heat shock-responsive cyclophilin from fava bean. Plant Cell (1994) 1.20

Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling. Proc Natl Acad Sci U S A (2003) 1.20

The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.19

A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus. J Cell Biol (1994) 1.19

Ion tolerance of Saccharomyces cerevisiae lacking the Ca2+/CaM-dependent phosphatase (calcineurin) is improved by mutations in URE2 or PMA1. Genetics (1998) 1.18

Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation. Neuron (2012) 1.18

The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J (1994) 1.17

The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (2002) 1.16

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest (1994) 1.15

Real-time monitoring of calcineurin activity in living cells: evidence for two distinct Ca2+-dependent pathways in fission yeast. Mol Biol Cell (2006) 1.14

Molecular characterization of a FKBP-type immunophilin from higher plants. Proc Natl Acad Sci U S A (1996) 1.13

The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster. PLoS Genet (2013) 1.13

Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity. Mol Biol Cell (1993) 1.12

An essential function of a phosphoinositide-specific phospholipase C is relieved by inhibition of a cyclin-dependent protein kinase in the yeast Saccharomyces cerevisiae. Genetics (1998) 1.08

Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice. J Physiol (2006) 1.08

FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med (1995) 1.07

Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochem J (2002) 1.07

Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med (1993) 1.07

Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? Cell Commun Signal (2009) 1.06

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest (1996) 1.06

Mg2+ deprivation elicits rapid Ca2+ uptake and activates Ca2+/calcineurin signaling in Saccharomyces cerevisiae. Eukaryot Cell (2007) 1.06

Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes. J Exp Med (1994) 1.05

Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol (2004) 1.04

Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C. Proc Natl Acad Sci U S A (1993) 1.03

Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res (2011) 1.03

NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology (2005) 1.02

Articles by these authors

The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell (1989) 8.60

Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73

Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication. Mol Cell Biol (1987) 2.50

Seizures in a patient treated with continuous povidone-iodine mediastinal irrigation. N Engl J Med (1992) 2.07

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J (1994) 2.03

Overlapping octamer and TAATGARAT motifs in the VF65-response elements in herpes simplex virus immediate-early promoters represent independent binding sites for cellular nuclear factor III. J Virol (1989) 1.98

Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem (1990) 1.90

On the cloning of eukaryotic total poly(A)-RNA populations in Escherichia coli. J Biol Chem (1980) 1.89

Unusual sites of metastases. Semin Oncol (1977) 1.80

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia (1997) 1.66

Transposon Tn5 encodes streptomycin resistance in nonenteric bacteria. J Bacteriol (1984) 1.65

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes Metab (2010) 1.63

Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut (1998) 1.61

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication. Antimicrob Agents Chemother (1984) 1.58

The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry (1998) 1.51

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications (2001) 1.49

DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol (1995) 1.48

Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem (1999) 1.47

A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem (1995) 1.46

T cell responses in calcineurin A alpha-deficient mice. J Exp Med (1996) 1.44

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J (1997) 1.42

Growth hormone gene expression in eukaryotic cells directed by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter. Gene (1985) 1.39

Organization and expression of the major genes from the long inverted repeat of the human cytomegalovirus genome. Virology (1986) 1.38

Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. J Biol Chem (1992) 1.31

The effect of sodium salicylate and aspirin on NF-kappa B. Science (1995) 1.31

Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem (1998) 1.30

Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J Biol Chem (1990) 1.30

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab (2011) 1.28

Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J Biol Chem (2000) 1.26

A rapid and sensitive method for detection and quantification of calcineurin and calmodulin-binding proteins using biotinylated calmodulin. Proc Natl Acad Sci U S A (1985) 1.22

Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer (2000) 1.22

Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse. Exp Parasitol (1982) 1.19

Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain. J Biol Chem (1984) 1.19

Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett (1998) 1.18

The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J (1994) 1.17

In vivo three-dimensional knee kinematics using a biplanar image-matching technique. Clin Orthop Relat Res (2001) 1.17

Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide. J Immunol (1988) 1.17

Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol (1990) 1.16

Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. Brain Res Dev Brain Res (1991) 1.16

Recombination deficient mutant of Caulobacter crescentus. Mol Gen Genet (1985) 1.14

Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Relationship of subunit structure to activity assessed by radiation inactivation. J Biol Chem (1981) 1.09

Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates. Methods Enzymol (1988) 1.07

Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med (1993) 1.07

Eosinophilic gastroenteritis presenting with acute pancreatitis. J Med (1997) 1.06

Regulation of IkB alpha phosphorylation by PKC- and Ca(2+)-dependent signal transduction pathways. J Immunol (1995) 1.06

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol (1998) 1.06

Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex. J Biol Chem (1994) 1.05

Risk of acute renal failure in patients with Type 2 diabetes mellitus. Diabet Med (2012) 1.03

Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology (2000) 1.03

Bioactive titanium: effect of sodium removal on the bone-bonding ability of bioactive titanium prepared by alkali and heat treatment. J Biomed Mater Res (2001) 1.03

Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum. Proc Natl Acad Sci U S A (1992) 1.02

Characterization of a major early gene from the human cytomegalovirus long inverted repeat; predicted amino acid sequence of a 30-kDa protein encoded by the 1.2-kb mRNA. Virology (1986) 1.00

The Ca2+/calmodulin-activated, phosphoprotein phosphatase calcineurin is sufficient for positive transcriptional regulation of the mouse IL-4 gene. Int Immunol (1994) 1.00

IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J Immunol (1997) 1.00

Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci (1994) 0.99

Role of the flagellum in cell-cycle-dependent expression of bacteriophage receptor activity in Caulobacter crescentus. J Bacteriol (1989) 0.98

Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. Proc Natl Acad Sci U S A (1987) 0.97

Calmodulin-dependent protein phosphatase from Neurospora crassa. Molecular cloning and expression of recombinant catalytic subunit. J Biol Chem (1991) 0.97

Molecular basis for p38 protein kinase inhibitor specificity. Biochemistry (1998) 0.97

Regulation of chondroitin sulfate biosynthesis by specific sulfation: acceptor specificity of serum beta-GalNAc transferase revealed by structurally defined oligosaccharides. Glycobiology (1997) 0.97

The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J (1994) 0.96

Systemic plasmacytosis with deposition of interleukin (IL)-6 and elevated expression of IL-6 mRNA in the skin lesions. Br J Dermatol (1998) 0.96

Interleukin 18 in acute myocardial infarction. Heart (2000) 0.95

Cyclic 3',5'-AMP phosphodiesterase in Physarum polycephalum. I. Chemotaxis toward inhibitors and cyclic nucleotides. Biochim Biophys Acta (1979) 0.95

Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin. Am J Hematol (2004) 0.95

Effect of high amounts of dietary zinc and age upon tissue zinc in young chicks. Poult Sci (1976) 0.95

Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus. Infect Immun (1979) 0.95

Molecular cloning of a calmodulin-dependent phosphatase from murine testis: identification of a developmentally expressed nonneural isoenzyme. Proc Natl Acad Sci U S A (1992) 0.94

Purification and properties of calmodulin-activated cyclic nucleotide phosphodiesterase from mammalian brain. Methods Enzymol (1988) 0.94

Vasa vasorum and vascular lesions in the human abdominal aorta. Vasa (1977) 0.93

The modified Spitzy shelf operation for patients with dysplasia of the hip. A 24-year follow-up study. J Bone Joint Surg Br (2002) 0.93

Activation of the interleukin-4 gene is controlled by the unique calcineurin-dependent transcriptional factor NF(P). J Biol Chem (1994) 0.92

Preparation of fluorescent, cross-linking, and biotinylated calmodulin derivatives and their use in studies of calmodulin-activated phosphodiesterase and protein phosphatase. Methods Enzymol (1988) 0.92

Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J Biol Chem (1982) 0.92

Periodic synthesis of phospholipids during the Caulobacter crescentus cell cycle. J Bacteriol (1987) 0.92

Structure and expression of two isoforms of the murine calmodulin-dependent protein phosphatase regulatory subunit (calcineurin B). Biochem Biophys Res Commun (1992) 0.92

Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231. Mol Pharmacol (1999) 0.91

Effects of spermine on activity and stability of calcium-dependent guanosine 3',5'-monophosphate phosphodiesterase. J Biol Chem (1979) 0.91

Plasma cell leukaemia with alpha-interferon therapy in myeloma. Br J Haematol (1992) 0.91

Differential subcellular localization of neural isoforms of the catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin) in central nervous system neurons: immunohistochemistry on formalin-fixed paraffin sections employing antigen retrieval by microwave irradiation. J Histochem Cytochem (1996) 0.91

Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol (1987) 0.90

Kinetic mechanism for p38 MAP kinase. Biochemistry (1997) 0.90

Chemotaxis toward carbohydrates and amino acids in Physarum polycephalum. Exp Cell Res (1978) 0.90

Bioactive bone cements containing nano-sized titania particles for use as bone substitutes. Biomaterials (2005) 0.90

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. Diabetes Obes Metab (2011) 0.89

A new bioactive bone cement consisting of BIS-GMA resin and bioactive glass powder. J Appl Biomater (1993) 0.88

A new technique for drug susceptibility tests for Plasmodium falciparum by ethidium bromide fluoroassay. Trans R Soc Trop Med Hyg (1986) 0.88

Testis-specific calmodulin-dependent phosphodiesterase. A distinct high affinity cAMP isoenzyme immunologically related to brain calmodulin-dependent cGMP phosphodiesterase. J Biol Chem (1988) 0.88

The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. Mol Cell Biol (1991) 0.88

Myelodysplastic syndrome with eosinophilia in bone marrow. Gunma Haematology Study Group. Br J Haematol (1993) 0.88

Mineral deficiencies in grazing dairy cattle in Kordofan and Darfur regions in western Sudan. Trop Anim Health Prod (1998) 0.88

Affinity chromatography of brain cyclic nucleotide phosphodiesterase using 3-(2-pyridyldithio)propionyl-substituted calmodulin linked to thiol-sepharose. Biochemistry (1983) 0.88

Identification of calmodulin-binding proteins. Methods Enzymol (1990) 0.88

Candida septic arthritis of the hip in a young patient without predisposing factors. J Bone Joint Surg Br (2003) 0.87

The effect of oilseeds in diets of lactating cows on milk production and methane emissions. J Dairy Sci (2002) 0.87